10 reports

## Global RNAi Technologies Market, By Region Market Forecast (2015-2027) (US $MN) Table ## Global RNAi Technologies Market, By Therapeutics Market Forecast (2015-2027) (US $MN) Table ## Global RNAi Technologies Market, By Ocular disorders

  • Genomics Proteomics And Enabling Technology
  • RNAi Technology
  • United States
  • Market Size

It offers RNAi technology platform GalXCTM, which is a advances the development of next-generation RNAi-based therapies that is designed to silence disease-driving genes in the liver.

  • Hepatitis
  • RNAi Technology
  • United States
  • Company
  • Dicerna Pharmaceuticals, Inc.

Agrow: RNAi

2613 2980 2324

It details company and product profiles, and activities and pipelines of specialist companies and research institutes engaged in RNAi technology.

  • Genomics Proteomics And Enabling Technology
  • RNAi Technology
  • United States
  • Litigation And Patent

Roche will use Tekmira' s SNALP technology for two RNAi product candidates.

  • RNAi Technology
  • United States
  • Company
  • Corporate Finance
  • Arbutus Biopharma Corporation
  • STP-703
  • STP-805

It is developed based on RNAi technology.

  • RNAi Technology
  • China
  • United States
  • Company Operations
  • Sirnaomics, Inc.

Roche will use Tekmira' s SNALP technology for two RNAi product candidates.

  • RNAi Technology
  • United States
  • Company
  • Corporate Finance
  • Tekmira Pharmaceuticals Corporation

RNAi for Therapeutic Applications: Technology and Market Forecast 2015-2025: Prospects for siRNAs, shRNAs and ddRNAi Approaches Table of Contents ##.

  • Genomics Proteomics And Enabling Technology
  • RNAi Technology
  • Therapy
  • World
  • Market Size
  • RXI PHARMACEUTICALS CORPORATION - DRUG PROFILES

The drug therapy is developed on RNA interference (RNAi) technology.

  • RNAi Technology
  • Therapy
  • United States
  • Company Operations
  • RXi Pharmaceuticals Corporation

The drug candidate is based on RNAi Technology and LNP technology.

  • Pharmaceutical
  • RNAi Technology
  • United States
  • Company Operations
  • Alnylam Pharmaceuticals, Inc.

Global RNA Interference (RNAi) Therapy Market Outlook 2018 ##.

  • Genomics Proteomics And Enabling Technology
  • RNAi Technology
  • Therapy
  • World